🔍 Exploring Hypertrophic Cardiomyopathy (HCM) - a must-know topic in cardiology. Keep reading for a high-yield overview! 💙 #Cardiology #HCM #MedX

At glass.health, physicians design the AI products that they will one day use when caring for patients. Physician-led product design is one of the many secret ingredients behind the love providers have for Glass Health 🖤🩺 Glass Health Initialized Capital Y Combinator

📜CardioNerds #USCardiology Article Alert‼️ "Secondary Mitral Regurgitation: Diagnosis and Management" by Dhaduk, Ibrahim, et al. 🔗uscjournal.com/articles/secon…

🦠🫀Learn all about infective endocarditis through this tweetorial created by some incredible educators Glass Health! ⤵️ #MedEd #MedTwitter #FOAMed #MedX

Need a fly-by consult 🥼 or have a specific clinical question 🩻? Glass Health Consult feature has you covered 🤝 #MedX #MedTwitter #AI #AICDS

Fight or Flight - An Overview of Adrenal Insufficiency 🥊 Learn some unintuitive pearls about Adrenal Insufficiency with a high-yield Glass Health 🧵 👇 #MedTwitter #MedX 1/21

How can Glass Consult AI clinical decision support help providers interpret important diagnostic tests 🧪 ? Let's look at a clinical reference question about laboratory testing for adrenal insufficiency 🤒 #AICDS #MedX #MedTwitter 1/4

The Glass Health Team is exceptionally proud to announce our participation in the inaugural Google for Startups AI-FIrst program.🥳✨ We'll present our mission to empower providers and patients with best-in-class AI tomorrow at the #GoogleCloudNext Startup Showcase 🖤🩺

This is so exciting!! 🚀Hearty congratulations, Glass Health fam!! 🎉

1/19 A young woman with mitral valve prolapse (MVP) comes to your office. She is anxious after reading about a potential link to sudden cardiac death (SCD). In this thread, we will explore how to recognize and manage the rare form of malignant MVP!

Breaking Down Bradycardia 🕰️ Slow heart rate with potential big impact. Dive into this high-yield 🧵 from Glass Health #MedTwitter #MedX #MedED #Cardiology #ACC2024 1/16

The decision to pursue invasive but life-saving medical interventions, such as pacemaker implantation, can be challenging 💉 Watch Glass Consult provide information on pacemaker indications in bradycardia using physician-validated AI context. #AICDS #MedX #MedTwitter 1/4

The future is here. AI clinical decision support tools like Glass Health won't replace clinical judgement but when harnessed correctly can allow us to provide better and more equitable care to all stakeholders! I have loved working on this so please try it out yourself and I

Great for #MedTwitter, but really anyone with something to learn A quick, easy, mostly passive way to learn things you often otherwise have to memorize… Just use your phone's Home Screen Here's how:

🖥️🩺 Dive into the world of digital health w/ the newest CardioNerds episode! ➡️ Ep. 366: Integrating Digital Health into Practice 🌟-ing Drs. Alexis Beatty & Seth Martin along w/ Drs. Nino Isakadze, Karan Desai MD FACC, & Daniel Ambinder, MD! 🔗 Listen now: cardionerds.com/366-digital-he…!

We are thrilled to announce that @GlasshealthHQ is 1 of 6 finalists for the Reuters Digital Health's Start Up Challenge 2024. 🎉🌟 Glass Health will present the deep benefits of empowering providers with the best-in-class AI CDS to health system leaders nationwide #AICDS

🎧 Don't miss the latest @Cardionerds GLP-1 receptor agonist episode‼️ Join Gurleen Kaur, MD, Richard Ferraro, FIT lead Spencer Carter, & expert Dr. Neha Pagidipati as they explore the clinical implementation of GLP-1 receptor agonists. cardionerds.com/367-glp-1-agon…

🔥#USCardiology Review, the official Journal of CardioNerds, now accepts clinical images ‼️ 📸Submit your interesting images today! 🫱🏽‍🫲🏿In partnership with Radcliffe Cardiology 🔗uscjournal.com Enjoy! ❤️🤓

Excited to launch a series of #Cardiology imaging infographics, starting with a classic: TAPSE! These are meant to be quick, bite-sized graphics discussing key points for #MedEd Grateful to all CardioNerds for support! If any comments, feel free to share below

Join us and follow for live updates as the CardioNerds academy fellows of House Einthoven facilitate discussion of the SEQUOIA-HCM trial with field experts this Wednesday, Nov 20 at 8PM EST on X!